StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models.

Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is a big problem: size.

Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing ...

Sometimes plants are so similar to each other that the methods developed by 18th century scientist Carl Linnaeus for identifying species are not enough. Completely new species of daisies have been ...

Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...

As diabetes cases increased since then, it became clear that a more efficient method was essential. Enter recombinant DNA technology in the 1980s: scientists developed a method to insert the human ...

These CENP-A proteins ensure that divided genetic information is kept intact during mitosis.

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...

DYAI READ THE FULL DYAI RESEARCH REPORT 3Q:24 Operational & Financial Results Dyadic International Inc. (NASDAQ: DYAI) ...

Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms ...

Techniques such as Polymerase Chain Reaction (PCR), CRISPR-Cas9 gene editing, and recombinant DNA technology have ...